In individuals with CAPS, gain-of-function mutations of the NLRP3 gene result in the excessive activation of NLRP3 inflammasome that cause sustained and uncontrolled release of IL-1β. The gene discussed is IL1B; the disease is cryopyrin-associated periodic syndrome.